In vivo generation of anti-BCMA CAR-T cells in relapsed or refractory multiple myeloma: a phase 1 study

Journal:
Nature Medicine
Published:
DOI:
10.1038/s41591-026-04244-6
Affiliations:
5
Authors:
13
Go to article
Institutions Authors Share
Tongji Hospital (TJH), HUST, China
10.666667
10.666667
 0.82
Shenzhen Pregene Biopharma Co. Ltd., China
1.000000
 0.08
EsoBiotec, Belgium
1.000000
 0.08
MOE Key Laboratory of Vascular Aging, HUST, China
0.333333
 0.03
Interested in Oncology and Carcinogenesis?